Your browser doesn't support javascript.
Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia.
Tadmor, Tamar; Benjamini, Ohad; Braester, Andrei; Rahav, Galia; Rokach, Lior.
  • Tadmor T; Hematology Unit, Bnai Zion Medical Center, Haifa, Israel.
  • Benjamini O; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Braester A; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel. Tamar.tadmor@b-zion.org.il.
  • Rahav G; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Tamar.tadmor@b-zion.org.il.
  • Rokach L; Department of Hematology, Galilee Medical Center, Nahariya, Israel.
Leukemia ; 35(9): 2727-2730, 2021 09.
Article in English | MEDLINE | ID: covidwho-1351931
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Vaccines / COVID-19 Drug Treatment / Antibodies, Viral Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01380-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Vaccines / COVID-19 Drug Treatment / Antibodies, Viral Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01380-5